首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >A dioxidovanadium (V) complex of NNO-donor Schiff base as a selective inhibitor of protein tyrosine phosphatase 1B: Synthesis, characterization, and biological activities
【24h】

A dioxidovanadium (V) complex of NNO-donor Schiff base as a selective inhibitor of protein tyrosine phosphatase 1B: Synthesis, characterization, and biological activities

机译:NNO-供体Schiff碱的二氧化维蒽铵(V)复合物作为蛋白酪氨酸磷酸酶1B的选择性抑制剂:合成,表征和生物活性

获取原文
获取原文并翻译 | 示例
           

摘要

A new dioxidovanadium (V) complex, VO2(HPPCH) (1) (H2PPCH = N'-picolinoylpyridin-1-ium-2-carbohydrazonate) has been synthesized and characterized by elemental analysis, IR, X-ray diffraction analysis and electrospray ionization mass spectra. Complex 1 crystallized in the monoclinic system with space group P2(1)/c. It potently inhibited PTP1B with IC50 of 0.13 mu M, about 7, 15 and 125-fold stronger against PTP1B than over TCPTP, SHP-1 and SHP-2, displaying obvious selectivity against PTP1B. Western blotting analysis indicated that complex 1 effectively increased the phosphorylation of PTP1B substrates, especially the phosphorylation of IR/IGF 1R and IRS-1. It exhibited lower cytotoxicity than positive control VOSO4. These results make complex 1 a promising candidate for novel anti-diabetic drug development. (C) 2017 Elsevier Masson SAS. All rights reserved.
机译:已经合成了一种新的二氧化二氧化钒(V)复合物,VO2(HPPCH)(1)(H2PPCH = N'-PICOLINOYLPYRIDIN-1-IUM-2-碳水化合物),其特征在于元素分析,IR,X射线衍射分析和电喷雾电离 质谱。 复合物1在具有空间组P2(1)/ c的单斜晶体系中结晶。 它易于抑制PTP1B,IC50较小,对PTP1B的IC50较强,而不是在TCPTP,SHP-1和SHP-2上,显示对PTP1B的明显选择性。 蛋白质印迹分析表明复合物1有效地增加了PTP1B基材的磷酸化,尤其是IR / IGF 1R和IRS-1的磷酸化。 它表现出比阳性对照效率低的细胞毒性。 这些结果使复合体成为新型抗糖尿病药物发育的有希望的候选者。 (c)2017年Elsevier Masson SAS。 版权所有。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号